Takeda Pharmaceutical
$18.129876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$18.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.17 (-0.90%) As of 3:10 PM EST today
-$0.17 (-0.90%) Today
Why Robinhood?
You can buy or sell TAK and other stocks, options, ETFs, and crypto commission-free!
About TAK
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. Read More The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Employees
49,578
Headquarters
Osaka, Osaka
Founded
1781
Market Cap
58.55B
Price-Earnings Ratio
—
Dividend Yield
2.65
Average Volume
1.37M
High Today
$18.46
Low Today
$18.05
Open Price
$18.46
Volume
1.18M
52 Week High
$21.61
52 Week Low
$16.10
Collections
TAK News
Analyst Ratings
83%
of 12 ratings
Buy
83%
Hold
17%
Sell
0%
TAK Earnings
$0.00
$0.39
$0.79
$1.18
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
$0.43 per share
Actual
Expected May 14, Pre-Market
People Also Bought
Pfizer
34,271
$33.88
-2.27%Gilead Sciences
17,818
$69.67
-4.43%Bristol-Myers Squibb
7,779
$62.12
-2.90%GE
329,537
$11.33
-4.51%AbbVie
27,043
$89.05
-4.39%CVS
22,686
$64.62
-4.86%Tencent
43,666
$50.63
+2.47%AT&T
105,269
$37.53
-1.37%Ford
385,493
$7.28
-3.88%Bank of America
118,029
$31.23
-4.58%Cisco
42,940
$42.47
-3.48%Teva Pharmaceutical
21,191